Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• Measles virus (MV) proteins are processed and presented by human leukocyte antigen (HLA) class II molecules.
• Previous work identified an MV phosphoprotein peptide (MV-P).
• Understanding T cell recognition of MV peptides is crucial for vaccine development.

Purpose of the Study:

• To identify and characterize T cell responses to MV nucleoprotein (MV-N) peptides.
• To investigate the association between HLA class II alleles and T cell responses to MV-P and MV-N peptides.
• To assess the potential of MV peptides for novel vaccine design.

Main Methods:

• Identification of MV-N peptide (SAGKVSSTLASELG) bound to HLA-DRB1*0301 using mass spectrometry.
• Analysis of peripheral blood mononuclear cells (PBMC) from 281 vaccinated subjects for peptide recognition by T cells.
• Measurement of gamma interferon (IFN-γ) and interleukin-4 (IL-4) cytokine responses.
• Statistical analysis of HLA-DRB1 allele associations with cytokine secretion.

Main Results:

• Significant IFN-γ responses to MV-P (55.9%) and MV-N (15.3%) peptides were observed.
• Interleukin-4 (IL-4) responses to MV-P (19.2%) and MV-N (23.1%) peptides were detected.
• Specific HLA-DRB1 alleles were strongly associated with MV-P and MV-N peptide-specific cytokine responses (e.g., DRB1*0301 for MV-P, DRB1*1501 for MV-N IFN-γ).

Conclusions:

• HLA class II-restricted MV proteins are processed and presented, eliciting cell-mediated immune responses.
• Identified MV peptides and their HLA associations provide valuable insights for designing targeted, peptide-based vaccines.
• Demonstrated T cell responsiveness to MV peptides supports their utility in future vaccine strategies.